{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:26:14Z","timestamp":1793737574209,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03455-x","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:08:54Z","timestamp":1783019334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-6901","authenticated-orcid":false,"given":"Priyanka","family":"Panchal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5904-8889","authenticated-orcid":false,"given":"Snehal","family":"Daware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-2314","authenticated-orcid":false,"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4272-6739","authenticated-orcid":false,"given":"Ganming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-5955","authenticated-orcid":false,"given":"Blase","family":"Billack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-2439","authenticated-orcid":false,"given":"Pulkit","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-0234","authenticated-orcid":false,"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"7","key":"3455_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","volume":"21","author":"D Accili","year":"2025","unstructured":"Accili D, Deng Z, Liu Q. Insulin resistance in type 2 diabetes mellitus. Nat Rev Endocrinol. 2025;21(7):413\u201326. https:\/\/doi.org\/10.1038\/s41574-025-01114-y.","journal-title":"Nat Rev Endocrinol"},{"key":"3455_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/ITT.S499605","volume":"14","author":"A Berbudi","year":"2025","unstructured":"Berbudi A, Khairani S, Tjahjadi AI. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. Immunotargets Ther. 2025;14:359\u201382. https:\/\/doi.org\/10.2147\/ITT.S499605.","journal-title":"Immunotargets Ther"},{"key":"3455_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031882","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen R. The role of obesity in type 2 diabetes mellitus-an overview. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031882.","journal-title":"Int J Mol Sci"},{"key":"3455_CR4","unstructured":"National Diabetes Statistics Report. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 15 Jun 2025."},{"issue":"3","key":"3455_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","volume":"33","author":"AM Chao","year":"2023","unstructured":"Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023;33(3):159\u201366. https:\/\/doi.org\/10.1016\/j.tcm.2021.12.008.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"3455_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234. https:\/\/doi.org\/10.1038\/s41392-024-01931-z.","journal-title":"Signal Transduct Target Ther"},{"key":"3455_CR7","unstructured":"The Use of Medicines in the U.S. 2023. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports-and-publications\/reports\/the-use-of-medicines-in-the-us-2023. Accessed 15 Jun 2025."},{"issue":"2","key":"3455_CR8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s40200-021-00899-9","volume":"20","author":"A Okamoto","year":"2021","unstructured":"Okamoto A, Yokokawa H, Nagamine T, Fukuda H, Hisaoka T, Naito T. Efficacy and safety of Semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. J Diabetes Metab Disord. 2021;20(2):2121\u20138. https:\/\/doi.org\/10.1007\/s40200-021-00899-9.","journal-title":"J Diabetes Metab Disord"},{"key":"3455_CR9","unstructured":"OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/209637s020s021lbl.pdf. Accessed 05 Jan 2026."},{"key":"3455_CR10","unstructured":"FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or. Accessed 05 Jan 2026."},{"issue":"12","key":"3455_CR11","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Svirskis D, Proft T, Loh J, Yin N, Li H, et al. Progress in peptide and protein therapeutics: challenges and strategies. Acta Pharm Sin B. 2025;15(12):6342\u201381. https:\/\/doi.org\/10.1016\/j.apsb.2025.10.026.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3455_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/cd19-0079","volume":"38","author":"S Hughes","year":"2020","unstructured":"Hughes S, Neumiller JJ. Oral Semaglutide. Clin Diabetes. 2020;38(1):109\u201311. https:\/\/doi.org\/10.2337\/cd19-0079.","journal-title":"Clin Diabetes"},{"key":"3455_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bioactmat.2022.02.025","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang W, Zhao R, Zhang X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater. 2022;15:392\u2013408. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.025.","journal-title":"Bioact Mater"},{"issue":"10","key":"3455_CR14","first-page":"627","volume":"102","author":"AM Semenya","year":"2020","unstructured":"Semenya AM, Wilson SA. Oral Semaglutide (Rybelsus) for the treatment of type 2 diabetes mellitus. Am Fam Physician. 2020;102(10):627\u20138.","journal-title":"Am Fam Physician"},{"key":"3455_CR15","unstructured":"RYBELSUS (semaglutide) tablets, for oral use Initial U.S. Approval: 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/213051s018lbl.pdf. Accessed 05 Jan 2026."},{"issue":"51","key":"3455_CR16","doi-asserted-by":"publisher","first-page":"35947","DOI":"10.1039\/d3ra06476j","volume":"13","author":"M Rahban","year":"2023","unstructured":"Rahban M, Ahmad F, Piatyszek MA, Haertle T, Saso L, Saboury AA. Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry. RSC Adv. 2023;13(51):35947\u201363. https:\/\/doi.org\/10.1039\/d3ra06476j.","journal-title":"RSC Adv"},{"issue":"6","key":"3455_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/psc.70016","volume":"31","author":"K Achilleos","year":"2025","unstructured":"Achilleos K, Petrou C, Nicolaidou V, Sarigiannis Y. Beyond efficacy: ensuring safety in peptide therapeutics through immunogenicity assessment. J Pept Sci. 2025;31(6):e70016. https:\/\/doi.org\/10.1002\/psc.70016.","journal-title":"J Pept Sci"},{"key":"3455_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11010030","author":"MR Ajmal","year":"2023","unstructured":"Ajmal MR. Protein misfolding and aggregation in proteinopathies: Causes, mechanism and cellular response. Diseases. 2023. https:\/\/doi.org\/10.3390\/diseases11010030.","journal-title":"Diseases"},{"issue":"4","key":"3455_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.drudis.2021.01.001","volume":"26","author":"SK Dubey","year":"2021","unstructured":"Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, et al. Oral peptide delivery: challenges and the way ahead. Drug Discov Today. 2021;26(4):931\u201350. https:\/\/doi.org\/10.1016\/j.drudis.2021.01.001.","journal-title":"Drug Discov Today"},{"key":"3455_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125888","volume":"681","author":"B Ongoren","year":"2025","unstructured":"Ongoren B, Kara A, Serrano DR, Lalatsa A. Novel enabling strategies for oral peptide delivery. Int J Pharm. 2025;681:125888. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125888.","journal-title":"Int J Pharm"},{"issue":"4","key":"3455_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","volume":"7","author":"AZ Alkilani","year":"2015","unstructured":"Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438\u201370. https:\/\/doi.org\/10.3390\/pharmaceutics7040438.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3455_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12551-025-01317-7","volume":"17","author":"RF Maia","year":"2025","unstructured":"Maia RF, Machado P, Rodrigues RO, Faustino V, Schutte H, Gassmann S, et al. Recent advances and perspectives of MicroNeedles for biomedical applications. Biophys Rev. 2025;17(3):909\u201328. https:\/\/doi.org\/10.1007\/s12551-025-01317-7.","journal-title":"Biophys Rev"},{"key":"3455_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12060569","author":"AJ Guillot","year":"2020","unstructured":"Guillot AJ, Cordeiro AS, Donnelly RF, Montesinos MC, Garrigues TM, Melero A. Microneedle-based delivery: an overview of current applications and trends. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12060569.","journal-title":"Pharmaceutics"},{"key":"3455_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/polym13162815","author":"FK Aldawood","year":"2021","unstructured":"Aldawood FK, Andar A, Desai S. A comprehensive review of microneedles: types, materials, processes, characterizations and applications. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13162815.","journal-title":"Polymers"},{"issue":"1","key":"3455_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11095-023-03621-x","volume":"41","author":"D Ando","year":"2024","unstructured":"Ando D, Ozawa A, Sakaue M, Yamamoto E, Miyazaki T, Sato Y, et al. Fabrication and characterization of dissolving microneedles for transdermal drug delivery of apomorphine hydrochloride in Parkinson\u2019s Disease. Pharm Res. 2024;41(1):153\u201363. https:\/\/doi.org\/10.1007\/s11095-023-03621-x.","journal-title":"Pharm Res"},{"key":"3455_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040579","author":"J He","year":"2021","unstructured":"He J, Zhang Z, Zheng X, Li L, Qi J, Wu W, et al. Design and evaluation of dissolving microneedles for enhanced dermal delivery of propranolol hydrochloride. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040579.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3455_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-023-00658-y","volume":"25","author":"X Luo","year":"2023","unstructured":"Luo X, Yang L, Cui Y. Microneedles: materials, fabrication, and biomedical applications. Biomed Microdevices. 2023;25(3):20. https:\/\/doi.org\/10.1007\/s10544-023-00658-y.","journal-title":"Biomed Microdevices"},{"key":"3455_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122989","volume":"640","author":"S Palekar","year":"2023","unstructured":"Palekar S, Mamidi HK, Guo Y, Vartak R, Patel K. Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions. Int J Pharm. 2023;640:122989. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122989.","journal-title":"Int J Pharm"},{"issue":"26","key":"3455_CR29","doi-asserted-by":"publisher","first-page":"29577","DOI":"10.1021\/acsami.2c05795","volume":"14","author":"D Jang","year":"2022","unstructured":"Jang D, Tang J, Schwendeman SP, Prausnitz MR. Effect of surface interactions on microsphere loading in dissolving microneedle patches. ACS Appl Mater Interfaces. 2022;14(26):29577\u201387. https:\/\/doi.org\/10.1021\/acsami.2c05795.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3455_CR30","doi-asserted-by":"publisher","unstructured":"Chanabodeechalermrung B, Chaiwarit T, Chaichit S, Udomsom S, Baipaywad P, Worajittiphon P, et al. HPMC\/PVP K90 dissolving microneedles fabricated from 3D-printed master molds: impact on microneedle morphology, mechanical strength, and topical dissolving property. Polymers (Basel). 2024;16(4). https:\/\/doi.org\/10.3390\/polym16040452.","DOI":"10.3390\/polym16040452"},{"key":"3455_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01737-0","author":"L Li","year":"2024","unstructured":"Li L, Anjani QK, Hutton ARJ, Li M, Sabri AHB, Vora L, et al. Evaluation of physical and chemical modifications to drug reservoirs for stimuli-responsive microneedles. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01737-0.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3455_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41551-020-00672-y","volume":"5","author":"Z Wang","year":"2021","unstructured":"Wang Z, Luan J, Seth A, Liu L, You M, Gupta P, et al. Microneedle patch for the ultrasensitive quantification of protein biomarkers in interstitial fluid. Nat Biomed Eng. 2021;5(1):64\u201376. https:\/\/doi.org\/10.1038\/s41551-020-00672-y.","journal-title":"Nat Biomed Eng"},{"key":"3455_CR33","doi-asserted-by":"publisher","unstructured":"Ando D, Miyatsuji M, Sakoda H, Yamamoto E, Miyazaki T, Koide T, et al. Mechanical characterization of dissolving microneedles: factors affecting physical strength of needles. Pharmaceutics. 2024;16(2). https:\/\/doi.org\/10.3390\/pharmaceutics16020200.","DOI":"10.3390\/pharmaceutics16020200"},{"issue":"39","key":"3455_CR34","doi-asserted-by":"publisher","first-page":"54553","DOI":"10.1021\/acsami.5c13207","volume":"17","author":"OE Fandino","year":"2025","unstructured":"Fandino OE, McPeake LK, Li H, Li Y, Donnelly RF. Strategic modulation of Isoniazid solubility through cocrystal formation for long-acting microneedle therapy of Tuberculosis. ACS Appl Mater Interfaces. 2025;17(39):54553\u201362. https:\/\/doi.org\/10.1021\/acsami.5c13207.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3455_CR35","doi-asserted-by":"publisher","unstructured":"Dawud H, Abu Ammar A. Rapidly dissolving microneedles for the delivery of steroid-loaded nanoparticles intended for the treatment of inflammatory skin diseases. Pharmaceutics. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020526.","DOI":"10.3390\/pharmaceutics15020526"},{"issue":"4","key":"3455_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/bm401524h","volume":"15","author":"JJ Roberts","year":"2014","unstructured":"Roberts JJ, Elder RM, Neumann AJ, Jayaraman A, Bryant SJ. Interaction of hyaluronan binding peptides with glycosaminoglycans in poly(ethylene glycol) hydrogels. Biomacromol. 2014;15(4):1132\u201341. https:\/\/doi.org\/10.1021\/bm401524h.","journal-title":"Biomacromol"},{"key":"3455_CR37","doi-asserted-by":"publisher","unstructured":"Jugl A, Pekar M. Hyaluronan-arginine interactions-an ultrasound and ITC study. Polymers (Basel). 2020;12(9). https:\/\/doi.org\/10.3390\/polym12092069.","DOI":"10.3390\/polym12092069"},{"issue":"8","key":"3455_CR38","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","volume":"11","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: challenges, status quo and future perspectives. Acta Pharm Sin B. 2021;11(8):2416\u201348. https:\/\/doi.org\/10.1016\/j.apsb.2021.04.001.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"3455_CR39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/jps.24425","volume":"104","author":"T Han","year":"2015","unstructured":"Han T, Das DB. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin. J Pharm Sci. 2015;104(6):1993\u20132007. https:\/\/doi.org\/10.1002\/jps.24425.","journal-title":"J Pharm Sci"},{"key":"3455_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.125128","volume":"670","author":"B Xu","year":"2025","unstructured":"Xu B, Liu H, Yang G, Zhang S, Zhou Z, Gao Y. Novel double-layered PLGA microparticles-dissolving microneedle (MPs-DMN) system for peptide drugs sustained release by transdermal delivery. Int J Pharm. 2025;670:125128. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125128.","journal-title":"Int J Pharm"},{"issue":"2","key":"3455_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40262-020-00951-6","volume":"60","author":"JN Clements","year":"2021","unstructured":"Clements JN, Isaacs D, Hartman RE, Gambill K. Pharmacokinetics and clinical implications of oral semaglutide for type 2 diabetes mellitus. Clin Pharmacokinet. 2021;60(2):153\u201363. https:\/\/doi.org\/10.1007\/s40262-020-00951-6.","journal-title":"Clin Pharmacokinet"},{"key":"3455_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106040","volume":"167","author":"M Rabiei","year":"2021","unstructured":"Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, et al. Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity. Eur J Pharm Sci. 2021;167:106040. https:\/\/doi.org\/10.1016\/j.ejps.2021.106040.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3455_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/abt\/tbad022","volume":"6","author":"S Ren","year":"2023","unstructured":"Ren S. Effects of arginine in therapeutic protein formulations: a decade review and perspectives. Antibody Ther. 2023;6(4):265\u201376. https:\/\/doi.org\/10.1093\/abt\/tbad022.","journal-title":"Antibody Ther"},{"key":"3455_CR44","doi-asserted-by":"publisher","unstructured":"Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017;7(6):20170030. https:\/\/doi.org\/10.1098\/rsfs.2017.0030.","DOI":"10.1098\/rsfs.2017.0030"},{"issue":"4","key":"3455_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.xphs.2017.11.015","volume":"107","author":"P Startzel","year":"2018","unstructured":"Startzel P. Arginine as an excipient for protein freeze-drying: a mini review. J Pharm Sci. 2018;107(4):960\u20137. https:\/\/doi.org\/10.1016\/j.xphs.2017.11.015.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3455_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/pro.3","volume":"18","author":"NK Jain","year":"2009","unstructured":"Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009;18(1):24\u201336. https:\/\/doi.org\/10.1002\/pro.3.","journal-title":"Protein Sci"},{"issue":"12","key":"3455_CR47","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1021\/bi047528r","volume":"44","author":"BM Baynes","year":"2005","unstructured":"Baynes BM, Wang DI, Trout BL. Role of arginine in the stabilization of proteins against aggregation. Biochemistry. 2005;44(12):4919\u201325. https:\/\/doi.org\/10.1021\/bi047528r.","journal-title":"Biochemistry"},{"issue":"2","key":"3455_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/bioe.2020.0011","volume":"2","author":"NR Kale","year":"2020","unstructured":"Kale NR, Dutta D, Carstens W, Mallik S, Quadir M. Functional applications of polyarginine-hyaluronic acid-based electrostatic complexes. Bioelectricity. 2020;2(2):158\u201366. https:\/\/doi.org\/10.1089\/bioe.2020.0011.","journal-title":"Bioelectricity"},{"key":"3455_CR49","doi-asserted-by":"publisher","unstructured":"Snetkov P, Zakharova K, Morozkina S, Olekhnovich R, Uspenskaya M. Hyaluronic acid: the influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer. Polymers (Basel). 2020;12(8). https:\/\/doi.org\/10.3390\/polym12081800.","DOI":"10.3390\/polym12081800"},{"issue":"Pt 3","key":"3455_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144954","volume":"318","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li Y, Wu N, Xie C, Suo H, Li Y, et al. Effects of hyaluronic acid with different molecular weights and concentrations on skin optical clearing and collagen fibril structural characteristics. Int J Biol Macromol. 2025;318(Pt 3):144954. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144954.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3455_CR51","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1080\/10717544.2022.2125600","volume":"29","author":"H Kang","year":"2022","unstructured":"Kang H, Zuo Z, Lin R, Yao M, Han Y, Han J. The most promising microneedle device: present and future of hyaluronic acid microneedle patch. Drug Deliv. 2022;29(1):3087\u2013110. https:\/\/doi.org\/10.1080\/10717544.2022.2125600.","journal-title":"Drug Deliv"},{"key":"3455_CR52","doi-asserted-by":"publisher","unstructured":"Raje V, Palekar S, Banella S, Patel K. Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer. Pharmaceutics. 2022;14(10). https:\/\/doi.org\/10.3390\/pharmaceutics14102192.","DOI":"10.3390\/pharmaceutics14102192"},{"issue":"19","key":"3455_CR53","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/marc.201200354","volume":"33","author":"R Luxenhofer","year":"2012","unstructured":"Luxenhofer R, Han Y, Schulz A, Tong J, He Z, Kabanov AV, et al. Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun. 2012;33(19):1613\u201331. https:\/\/doi.org\/10.1002\/marc.201200354.","journal-title":"Macromol Rapid Commun"},{"key":"3455_CR54","doi-asserted-by":"publisher","unstructured":"Choo S, Jin S, Jung J. Fabricating high-resolution and high-dimensional microneedle mold through the resolution improvement of stereolithography 3D printing. Pharmaceutics. 2022;14(4). https:\/\/doi.org\/10.3390\/pharmaceutics14040766.","DOI":"10.3390\/pharmaceutics14040766"},{"key":"3455_CR55","doi-asserted-by":"publisher","unstructured":"Singh P, Vinikoor T, Sharma N, Nelson N, Prasadh S, Oiknine R, et al. Single-Administration self-boosting microneedle patch for the treatment of obesity. Adv Ther (Weinh). 2024;7(9). https:\/\/doi.org\/10.1002\/adtp.202400028.","DOI":"10.1002\/adtp.202400028"},{"issue":"26","key":"3455_CR56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029314","volume":"101","author":"Y Gao","year":"2022","unstructured":"Gao Y, Du L, Li Q, Li Q, Zhu L, Yang M, et al. How physical techniques improve the transdermal permeation of therapeutics: a review. Medicine (Baltimore). 2022;101(26):e29314. https:\/\/doi.org\/10.1097\/MD.0000000000029314.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"3455_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/87551225221092681","volume":"38","author":"A Fornes","year":"2022","unstructured":"Fornes A, Huff J, Pritchard RI, Godfrey M. Once-weekly Semaglutide for weight management: a clinical review. J Pharm Technol. 2022;38(4):239\u201346. https:\/\/doi.org\/10.1177\/87551225221092681.","journal-title":"J Pharm Technol"},{"key":"3455_CR58","unstructured":"Zosano presses on after FDA rejects Qtrypta migraine patch. https:\/\/www.fiercepharma.com\/drug-delivery\/zosano-slapped-complete-response-letter-for-microneedle-based-migraine-treatment. Accessed 05 Jun 2026."},{"key":"3455_CR59","doi-asserted-by":"publisher","unstructured":"McCrudden MT, Alkilani AZ, Courtenay AJ, McCrudden CM, McCloskey B, Walker C, et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res. 2015;5(1):3-14. https:\/\/doi.org\/10.1007\/s13346-014-0211-1","DOI":"10.1007\/s13346-014-0211-1"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03455-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:02:38Z","timestamp":1790280158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03455-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03455-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Post-mortem animal skin collected were used for experimental studies providing a reliable\n                      ex-vivo\n                      platform to assess SMG-DMNs performance under controlled conditions.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"249"}}